- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03901586
Satisfaction and Long-term Anatomic Efficacy Study on Patients Who Underwent a Richter Intervention in the Obstetric and Gynecology Department of Foch Hospital Since 2008 (RICHTER)
May 15, 2019 updated by: Hopital Foch
Satisfaction and Long-term Anatomic Efficacy will be assessed on Patients Who Underwent a Richter Intervention in the Obstetric and Gynecology Department of Foch Hospital Since 2008.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Satisfaction and Long-term Anatomic Efficacy will be assessed on Patients Who Underwent a Richter Intervention in the Obstetric and Gynecology Department of Foch Hospital Since 2008.
Study Type
Interventional
Enrollment (Actual)
88
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Suresnes, France, 92151
- Hôpital FOCH
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Patient who underwent a Richter intervention between 01/01/2008 and 31/12/2017 in the Gynecology Department of Foch Hospital
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Patients who had Richter intervention
|
Patient will be asked to assess their satisfaction concerning the Richter procedure and its long term effect
The Quality of life will be assessed with 3 questionnaires (I-Qol / PISQ-12/PFDI-20)
An optional gynecological consult is proposed to the patients to better estimate the gynecological long-term impact of the procedure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Long-term satisfaction of the Richter procedure
Time Frame: 4 months
|
It will be ask to the patients to evaluate their satisfaction of the procedure, base on a 4-answer scale ("Not at all satisfied", "Not very satisfied", "Moderately satisfied", "Fully satisfied")
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Long term anatomic impact of the procedure
Time Frame: 7 months
|
An optional gynecological consult is proposed to the patients
|
7 months
|
Post-operative complications
Time Frame: 7 months
|
Post-operative complications will be collected and compared to the anatomic impact of the procedure and the patient satisfaction
|
7 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Angeline Favre-Inhofer, Hôpital FOCH
- Study Director: Jean-Marc Ayoubi, Hôpital FOCH
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2018
Primary Completion (Actual)
April 30, 2019
Study Completion (Actual)
April 30, 2019
Study Registration Dates
First Submitted
April 2, 2019
First Submitted That Met QC Criteria
April 2, 2019
First Posted (Actual)
April 3, 2019
Study Record Updates
Last Update Posted (Actual)
May 16, 2019
Last Update Submitted That Met QC Criteria
May 15, 2019
Last Verified
November 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018_0072
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Genital Prolapse
-
Rennes University HospitalRecruiting
-
University of South FloridaCompletedProlapse GenitalUnited States
-
Melissa Fischer, MDWilliam Beaumont HospitalsTerminated
-
Hospices Civils de LyonCompleted
-
Karolinska InstitutetCompleted
-
Assiut UniversityNot yet recruiting
-
Centre Hospitalier Universitaire de NīmesTerminated
-
South Valley UniversityCompletedProlapse GenitalEgypt
-
Ain Shams UniversityCompleted
-
University of Sao PauloUniversity of Sao Paulo General Hospital; Federal University of São Paulo; Irmandade... and other collaboratorsUnknown
Clinical Trials on Satisfaction assessment
-
Hospices Civils de LyonCompletedChemotherapy Effect | G-CHOP Chemotherapy | R-CHOP ChemotherapyFrance
-
Centre hospitalier de l'Université de Montréal...Completed
-
Clin4allRecruitingPsoriasis of Scalp | Psoriasis Nail | Psoriasis Palmaris | Psoriasis Genital | Psoriasis PlantarisFrance
-
Centre Hospitalier Universitaire de BesanconUnknown
-
Centre Hospitalier Universitaire DijonRecruiting
-
Attune Health Research, Inc.Rheumatology Research FoundationRecruiting
-
University of ManitobaUnknownComplete EdentulismCanada
-
University of JordanCompleted
-
Centre Hospitalier Universitaire de NīmesCompletedSatisfaction, Patient | Surgery | AnesthesiologyFrance
-
Ain Shams UniversityBenha University; Misr University for Science and Technology; Kuwait Cancer Control... and other collaboratorsUnknown